Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Fesco launches new regular container train from Moscow to Omsk

10/4/23 FESH

Shareholders of Donskoy Factory of Radiocomponents approved dividends for 6 months 2023

10/4/23 DZRD

MD Medical will obtain a primary listing on the Moscow Exchange

10/4/23 MDMG

SPB Exchange summarized the results of trading in September

10/4/23 SPBE

Moscow Exchange warned HeadHunter of non-compliance with listing requirements

10/4/23 HEAD

PhosAgro shareholders decided not to pay dividends for 6 months of 2023

10/3/23 PHOR

Abrau-Durso started producing vodka

10/3/23 ABRD

Trading volume on Moscow Exchange in September increased by 67% year-on-year

10/3/23 MOEX

Cian will obtain a primary listing on the Moscow Exchange

10/3/23 CIAN

VK is getting more and more Yandex

10/3/23 VKCO